Trademark: ANOCCA 2060800
Word
ANOCCA
ID
2060800
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
16 July 2019
Registration Date
16 July 2019
Renewal Date
16 July 2029

Owner(s)
Service

Goods and Services:
Class 1:
Biochemicals, namely for in vitro genetic engineering use; biochemicals, namely for ex vivo genetic engineering use; biochemicals, namely precursors for in vitro genetic engineering use; biochemicals, namely precursors for ex vivo genetic engineering use; biological preparations; biological preparations, namely, for in vitro genetic engineering use; biological preparations, for ex vivo genetic engineering use; biological preparations, precursors for in vitro genetic engineering use; biological preparations, precursors for ex vivo genetic engineering use; biological preparations for use in manufacture; biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparations [other than for medical use]; biological preparations for use in industry and science; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; chemical reagents, namely, for in vitro genetic engineering use; chemical reagents, for ex vivo genetic engineering use; chemical reagents, precursors for in vitro genetic engineering use; chemical reagents, precursors for ex vivo genetic engineering use; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations, namely, for in vitro genetic engineering use; diagnostic preparations, for ex vivo genetic engineering use; diagnostic preparations, precursors for in vitro genetic engineering use; diagnostic preparations, precursors for ex vivo genetic engineering use; immunoassay reagents, other than for medical use; immunoassay reagents, namely, for in vitro genetic engineering use; immunoassay reagents, for ex vivo genetic engineering use; immunoassay reagents, precursors for in vitro genetic engineering use; immunoassay reagents, precursors for ex vivo genetic engineering use; immunoassays based on polypeptides for determining immunological profile, other than for medical use; reagents for use in immunoserology; reagents, namely, for in vitro genetic engineering use; reagents, namely, for ex vivo genetic engineering use; reagents, namely, precursors for in vitro genetic engineering use; reagents, namely, precursors for ex vivo genetic engineering use.
Class 5:
Biological preparations for veterinary and medical purposes; biological preparations for ex vivo gene engineering; biological preparations for cellular therapeutics; biological preparations for cellular therapy; biological preparations for cell therapy; biological preparations for treatment of deceases using cells; biological preparations for medical purposes; biological preparations for treatment of cancer; biological tissue cultures for medical purposes; cellular function activating agents for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparation and materials for veterinary and medical purposes; diagnostic preparation for medical use; diagnostic preparations; diagnostic preparations for medical purposes; immunoassay reagents for medical use; immunomodulators; immunostimulants; in vitro diagnostic preparation for medical use; mixed biological preparations for medical purposes; personalized antigens; personalized tumour antigens; personalized tumour vaccines; personalized vaccines; pharmaceutical compositions; pharmaceutical compositions and substances with anti-inflammatory properties; pharmaceutical compositions for the prevention of autoimmune conditions; pharmaceutical compositions for the prevention of autoimmune diseases; pharmaceutical compositions for the prevention of autoimmune disorders; pharmaceutical compositions for the prevention of inflammatory conditions; pharmaceutical compositions for the prevention of inflammatory disorders; pharmaceutical compositions for the prevention of inflammatory diseases; pharmaceutical compositions for the prevention of oncological conditions; pharmaceutical compositions for the prevention of oncological disorders; pharmaceutical compositions for the prevention of oncological diseases; pharmaceutical compositions for the prevention of tumours; pharmaceutical compositions for the treatment of autoimmune conditions; pharmaceutical compositions for the treatment of autoimmune diseases; pharmaceutical compositions for the treatment of autoimmune disorders; pharmaceutical compositions for the treatment of inflammatory conditions; pharmaceutical compositions for the treatment of inflammatory disorders; pharmaceutical compositions for the treatment of inflammatory diseases; pharmaceutical compositions for the treatment of oncological conditions; pharmaceutical compositions for the treatment of oncological diseases; pharmaceutical compositions for the treatment of oncological disorders; pharmaceutical compositions for the treatment of tumours; pharmaceutical preparations; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with anti-inflammatory properties; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for medical purposes; pharmaceutical preparations for prevention of tumours; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of autoimmune conditions; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of inflammatory conditions; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention of oncological conditions; pharmaceutical preparations for the prevention of oncological disorders; pharmaceutical preparations for the prevention of oncological diseases; pharmaceutical preparations for the treatment of autoimmune conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammatory conditions; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of oncological conditions; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations for the treatment of oncological disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating rheumatological diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of digestive system disorders; pharmaceutical preparations for treatment of tumours; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; preparations for detecting genetic predispositions for medical purposes; prophylactic vaccines; reagents for use in medical genetic testing; tumour antigens; tumour vaccines; vaccines; vaccines for human use; viral vaccines.
Class 42:
Analysis in the field of molecular biology; analysis of human serum for medical research; analysis of human tissues for medical research; biochemical research and analysis; biochemical research in the field of ex vivo gene engineering; biochemical research in the field of cellular therapeutics; biochemical research in the field of cell therapy; biochemical research in the field of cellular therapy; biochemical research in the field of treatment of deceases using cells; biological laboratory services; biological research; biological research and analysis; biological research laboratory services; biological research services; biological research, clinical research and medical research; biomedical research services; biotechnology research; blood analysis services for scientific research purposes; cell separation research services; clinical trials; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials in the field of autoimmune disease therapy; conducting clinical trials in the field of cancer therapy; conducting clinical trials in the field of gene therapy; contract research services relating to molecular sciences; DNA screening for scientific research purposes; genetic engineering services; genetic engineering services relating to plants; genetic research; genetic testing for scientific research purposes; laboratory (scientific) services; laboratory research; laboratory research in the field of gene expression; laboratory research services relating to pharmaceuticals; laboratory testing services; laboratory services relating to the production of monoclonal antibodies; laboratory testing services; medical and pharmacological research services; medical laboratory services; medical research; medical research laboratory services; medical research services; pharmaceutical research and development; pharmaceutical research and development services; pharmaceutical research services; preparation of biological samples for analysis in research laboratories; preparation of biological samples for research purposes; preparation of biological samples for testing and analysis in research laboratories; product research and development; research and development for the pharmaceutical industry; research and development in the field of biotechnology; research and development in the field of diagnostic preparations; research and development in the field of immunology; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development of new products for third parties in the field of autoimmunity, cancer and rheumatoid heart disease; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; research and development services in the field of microorganisms and cells; research and development services relating to vaccines; research in the field of autoimmune disease; research in the field of gene therapy; research in the field of genetic engineering; research in the field of inflammatory diseases; research in the field of oncology; research laboratories; research laboratory services; research of pharmaceuticals; research on the subject of pharmaceuticals; research relating to biotechnology; research relating to medicine; research relating to molecular services; research relating to pharmaceuticals; research relating to science; research and development services in the field of immunology; scientific investigations for medical purposes; scientific laboratory services; scientific research; scientific research and analysis; scientific research and development; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous disease; scientific research in the field of genetics and genetic engineering; scientific research relating to biology; scientific research relating to cellular therapeutics; scientific research relating to genetics; scientific research relating to immuntherapeutics; scientific research relating to prophylactic vaccines; scientific research services; scientific services and research relating thereto; scientific services relating to the isolation and cultivation of human tissue and cells; scientific testing services.
Class 44:
Blood bank services; medical clinic services; therapy services; blood banks; medical clinics; clinic (medical-) services; health clinic services [medical]; medical and health care clinics; providing personalized therapy; providing personalized medical and health care services; provision of medical services; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to ex vivo gene engineering; medical testing services relating to cellular therapeutics; medical testing services relating to cell therapy; medical testing services relating to cellular therapy; medical testing services relating to treatment of deceases using cells; medical services relating to the removal, treatment and processing of human blood; medical services for the treatment of cancer, autoimmune disease or inflammatory disease; medical services for the treatment of conditions of the human body; medical screening services relating to oncological disease, autoimmune disease or inflammatory disease; medical care and analysis services relating to patient treatment; medical diagnostic services; medical health assessment services; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples taken from patients; medical analysis services; medical analysis services relating to the treatment of persons; medical analysis services relating the treatment of patients; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical and health services relating to DNA, genetics and genetic testing; medical and health care services; medical services in the field of oncology; genetic testing for medical purposes.